IPO registrations (S-1, F-1) · Registrants
MARIZYME, INC.
- SEC CIK
- 1413754 · filings on EDGAR ↗
- Former names
- MARIZYME INC (2018–2023); GBS Enterprises Inc (2010–2018); Swav Enterprises Ltd. (2007–2010)
- Registration
- Form S-1, first filed 2008-03-03, last 2023-10-12; 3 initial registrations, 9 amendments
- Outcome
- Declared effective 2008-04-01; withdrawal requested 2013-05-10
- Industry (SIC)
- Surgical & Medical Instruments & Apparatus 3841
- Incorporated in
- NV
- Business address
- 555 HERITAGE DRIVE, SUITE 205, Jupiter, FL 33458
- EIN
- 82-5464863
- EDGAR entity type
- operating
- Insiders and CEO pay
- MARIZYME, INC. on the corporate pages
Offering terms
- Shares offered
- 13,971,324
- Listing
- OTCQB under the symbol MRZM
- Lead underwriters
- Univest Securities
- Syndicate
- of Contents; Glossary of Life Science Terms
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: MARIZYME, INC. EXACT (EIN (EXACT, as the state registration reports it))
- Form 5500 plan sponsor: MARIZYME, INC. EXACT (EIN (EXACT))
- Form D issuer: MARIZYME, INC. EXACT (CIK (EXACT))
- SEC filer: GBS Enterprises Inc EXACT (CIK (EXACT))
- Person page: Dr Vithalbhai D Dhaduk Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director,Officer,TenPercentOwner))
Filings 16
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2008-03-03 | S-1/A | S-1/A (amendment) | Swav Enterprises Ltd. | 0001062993-08-000891 ↗ |
| 2008-03-20 | S-1/A | S-1/A (amendment) | Swav Enterprises Ltd. | 0001062993-08-001177 ↗ |
| 2008-04-01 | EFFECT | EFFECT (declared effective) | Swav Enterprises Ltd. | 9999999995-08-000951 ↗ |
| 2012-04-09 | S-1 | S-1 (registration) | GBS Enterprises Inc | 0001144204-12-020708 ↗ |
| 2012-07-19 | S-1/A | S-1/A (amendment) | GBS Enterprises Inc | 0001144204-12-040214 ↗ |
| 2013-05-10 | RW | RW (withdrawal request) | GBS Enterprises Inc | 0001144204-13-027718 ↗ |
| 2022-02-14 | S-1 | S-1 (registration) | MARIZYME INC | 0001493152-22-004297 ↗ |
| 2022-11-02 | S-1/A | S-1/A (amendment) | MARIZYME INC | 0001213900-22-068396 ↗ |
| 2022-11-16 | S-1/A | S-1/A (amendment) | MARIZYME INC | 0001213900-22-073164 ↗ |
| 2023-02-01 | S-1/A | S-1/A (amendment) | MARIZYME INC | 0001493152-23-003303 ↗ |
| 2023-02-09 | S-1/A | S-1/A (amendment) | MARIZYME INC | 0001493152-23-004099 ↗ |
| 2023-02-13 | S-1/A | S-1/A (amendment) | MARIZYME INC | 0001493152-23-004535 ↗ |
| 2023-04-21 | RW | RW (withdrawal request) | MARIZYME INC | 0001493152-23-013197 ↗ |
| 2023-07-18 | S-1 | S-1 (registration) | MARIZYME, INC. | 0001493152-23-024850 ↗ |
| 2023-10-12 | S-1/A | S-1/A (amendment) | MARIZYME, INC. | 0001493152-23-037019 ↗ |
| 2023-10-17 | EFFECT | EFFECT (declared effective) | MARIZYME, INC. | 9999999995-23-002997 ↗ |
Prospectus pages read 1
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2023-10-12 | S-1/A | registration statement | $1.33 | 13,971,324 | $18,581,860 | OTCQB MRZM | 3 | primary document; price line, shares headline, proceeds computed, cover names 2 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Fung Vanleo Y.W. | Director,Officer; Other | CFO,Secretary | 2 | 2008–2009 | |
| LAM PUI SHAN | Director,Officer,TenPercentOwner; Other | President | 2 | 2008–2009 | |
| Masselli Sandy J Jr | Director,Officer,TenPercentOwner | Chief Executive Officer | 1 | 2009 | |
| Ott Joerg | Director; Director,Officer; Director,Officer,TenPercentOwner | CEO AND CHAIRMAN; CEO and Chairman of the Board; CHIEF EXECUTIVE OFFICER | 4 | 2010–2013 | |
| LOTUS HOLDINGS LTD | TenPercentOwner | 1 | 2010 | ||
| Durst John Paul | Other | 6 | 2011–2012 | ||
| Durst Mark William | Other | 7 | 2011–2012 | ||
| BAKSA STEPHEN D | Director | 6 | 2012–2013 | ||
| DARSCH DAVID MICHAEL | Director | 1 | 2012 | ||
| ERNST MARKUS RAINER | Officer | Chief Financial Officer | 2 | 2012 | |
| MOORE JOHN A JR | Director | 4 | 2012–2013 | ||
| SHIHADAH MOHAMMAD AHMAD | Director | 1 | 2012 | ||
| ESC Holdings LLC | TenPercentOwner | 1 | 2018 | ||
| Gutierrez Juan Francisco | Director | 1 | 2018 | ||
| Schleipfer-Conley Emmanuelle | TenPercentOwner | 1 | 2018 | ||
| DeVito Nicholas | Officer | Interim CEO, Interim CFO | 1 | 2019 | |
| Brostowin Terry A | Director | 3 | 2020–2022 | ||
| Harmon Bruce | Officer | CFO; Chief Financial Officer | 2 | 2020 | |
| SAPIRSTEIN JAMES | Director,Officer; Director,OfficerOther | Interim CEO; Interim Chief Executive Office | 2 | 2020–2021 | |
| Chandrasekhar Satishchandran | Officer | Chief Operating Officer | 1 | 2020 | |
| Pachuk Catherine J. | Officer | Chief Science Officer | 1 | 2020 | |
| CAMPBELL NEIL J | Director,Officer | Chief Executive Officer | 1 | 2020 | |
| Very Donald Leroy JR | Officer | Executive Vice President | 1 | 2020 | |
| Brooks Steven Scott | Officer | Chief Medical Officer | 1 | 2020 | |
| Dhaduk Vithalbhai D | Director; Director,Officer,TenPercentOwner | Chairman of the Board | 3 | 2021–2023 | person page Fuzzy |
| Kampf Julie B. | Director | 2 | 2021–2022 | ||
| Barthel David | Director,Officer | Chief Executive Officer | 2 | 2022 | |
| Kovalyov Georgiy | Officer | Chief Financial Officer | 2 | 2022 | |
| Richmond Bradley | Officer | Acting VP of Finance | 1 | 2022 | |
| Ross Harrison | Officer | Vice President of Finance | 2 | 2022 | |
| STEWART MICHAEL R | Director | 2 | 2022 | ||
| Hearl William | Director | 3 | 2022 | ||
| Patel Nilesh Umedbhai | Director | 2 | 2022 | ||
| Braeden Lichti | TenPercentOwner | 3 | 2023 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2023-05-19 | MARIZYME, INC. | Biotechnology | $10,000,000 | $1,000,000 | 1 | 1 |
| 2023-05-10 | MARIZYME, INC. | Biotechnology | $265,216 | $265,216 | 4 | 1 |
| 2021-11-03 | MARIZYME INC | Biotechnology | $10,000,000 | $1,174,945 | 4 | 1 |
| 2021-10-19 | MARIZYME INC | Biotechnology | $10,000,000 | $1,174,945 | 4 | 1 |
| 2018-09-17 | MARIZYME INC | Biotechnology | $6,000,000 | $5,562,580 | 22 | 2 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | MARIZYME, INC. | FL | State business registries | name and state |
| Plan sponsor | MARIZYME, INC. | FL | Form 5500 (employee benefit plans) | EIN (EXACT) |
| Form D issuer | MARIZYME, INC. | FL | Form D private offerings | CIK (EXACT) |
| Patent assignee | Marizyme, Inc. | FL | Patents (USPTO) | name and state |
| SEC filer | MARIZYME, INC. | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | Marizyme, Inc. | FL | Trademarks (USPTO) | name and state |
| Form 5500 plan sponsor | MARIZYME, INC. | EIN (EXACT) | ||
| Person page | Dr Vithalbhai D Dhaduk | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director,Officer,TenPercentOwner) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Surgical & Medical Instruments & Apparatus, FL first:
- XOMED SURGICAL PRODUCTS INC FL
- AMERICAN SCIENTIFIC RESOURCES INC FL
- IRADIMED CORP FL
- Vicor Technologies, Inc. FL
- INVO Fertility, Inc. FL
- VYCOR MEDICAL INC FL
- InspireMD, Inc. FL
- Sensus Healthcare, Inc. FL
- TREACE MEDICAL CONCEPTS, INC. FL
- BRAIN SCIENTIFIC INC. FL
In other datasets, the same topic (Technology) in FL:
- Form D issuer: 3D FUTURE VISION II, INC. (Form D private offerings)
- Lobbying client: 1-800-DONOTCALL (Federal lobbying (LDA))
Interests: Surgical & Medical Instruments & Apparatus · Technology